Pulmonary Biomarker Surfactant Protein-B Is Used for Diagnosis
|
By LabMedica International staff writers Posted on 10 Dec 2008 |
|
Roche Diagnostics (Rotkreuz, Switzerland) and an Australian Biotech company, Southern Medical Diagnostics (SMD; Walkerville, Australia) signed licensing agreements on diagnostic applications of Surfactant Protein-B.
According to the agreements, Roche will have semi-exclusive worldwide rights for diagnostic applications of Surfactant Protein-B (SP-B) in lung disorders; SMD will have worldwide rights to key test-components developed by Roche, which SMD may exclusively use for SP-B applications.
A lung-specific protein and a key functional component of the alveolus, SP-B is present at very low concentrations in the serum of healthy people. It is released into the blood stream as a result of lung injury and is significantly increased in primary and secondary lung disorders affecting mainly the lung parenchyma. This includes the alveolocapillary system, such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and heart failure. Changes of lung disorders can be monitored by measuring levels of SP-B in the blood.
Together with B-type natriuretic peptide (BNP or NT-proBNP) tests, SP-B helps to discriminate between cardiac and non-cardiac causes of dyspnea.
"Roche Diagnostics believes that tests for Surfactant Protein-B will be very valuable in the diagnosis, differential diagnosis, and monitoring of patients with primary and secondary pulmonary disorders," said Dirk Ehlers, head of Roche Professional Diagnostics." He added, "The SP-B assay will allow earlier recognition of cardio-pulmonary conditions and thereby prepare the basis for improved treatment in the future."
Roche is one of the world's leading healthcare groups in the fields of diagnostics and pharmaceutics. The company is a world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology.
Southern Medical Diagnostics Pty Ltd. is a private Australian company specializing in the development and out-licensing of novel diagnostic technologies.
Related Links:
Roche Diagnostics
Southern Medical Diagnostics
According to the agreements, Roche will have semi-exclusive worldwide rights for diagnostic applications of Surfactant Protein-B (SP-B) in lung disorders; SMD will have worldwide rights to key test-components developed by Roche, which SMD may exclusively use for SP-B applications.
A lung-specific protein and a key functional component of the alveolus, SP-B is present at very low concentrations in the serum of healthy people. It is released into the blood stream as a result of lung injury and is significantly increased in primary and secondary lung disorders affecting mainly the lung parenchyma. This includes the alveolocapillary system, such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and heart failure. Changes of lung disorders can be monitored by measuring levels of SP-B in the blood.
Together with B-type natriuretic peptide (BNP or NT-proBNP) tests, SP-B helps to discriminate between cardiac and non-cardiac causes of dyspnea.
"Roche Diagnostics believes that tests for Surfactant Protein-B will be very valuable in the diagnosis, differential diagnosis, and monitoring of patients with primary and secondary pulmonary disorders," said Dirk Ehlers, head of Roche Professional Diagnostics." He added, "The SP-B assay will allow earlier recognition of cardio-pulmonary conditions and thereby prepare the basis for improved treatment in the future."
Roche is one of the world's leading healthcare groups in the fields of diagnostics and pharmaceutics. The company is a world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology.
Southern Medical Diagnostics Pty Ltd. is a private Australian company specializing in the development and out-licensing of novel diagnostic technologies.
Related Links:
Roche Diagnostics
Southern Medical Diagnostics
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA
Latest Molecular Diagnostics News
- New Liquid Biopsy Panel Targets Pediatric Cancers
- Finger Prick Blood Test to Enable Early Alzheimer’s Detection
- Smarter Blood Tests Deliver Faster Diagnoses and Improved Outcomes
- Single Metagenomic Next-Generation Sequencing Test Can Detect All Infectious Pathogens
- Cutting-Edge Diagnostic Tool Rapidly Identifies Emerging SARS-CoV-2 Variants
- Novel Method Analyzes Genetic Variations in Families with High Incidence of Breast Cancer
- cfDNA Testing Reduces Pregnancy Risks
- Non-Invasive Biosensor Facilitates Early Kidney Disease Detection
- New High-Sensitivity Cardiac Troponin Test Quickly Rules Out Heart Attack
- Gene Technology Outperforms Standard Newborn Screening Tests in Pioneering Study
- Maternal Blood Test Identifies Congenital Heart Diseases in Fetus
- Enhanced Ultra-Sensitive Protocol Detects Parkinson’s Disease Proteins in Extracellular Vesicles in Blood
- New RNA Molecules Can Help Predict Bowel Cancer Recurrence
- Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings
- Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’
- Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear
Channels
Clinical Chemistry
view channel.jpg "Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)")
POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more
Screening Tool Detects Multiple Health Conditions from Single Blood Drop
Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more
Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more
Hematology
view channel
First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more
Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more
Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more
Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read moreImmunology
view channel.jpg "Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)")
Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients
Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more.jpg "Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)")
Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival
A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more
Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients
Immunotherapy aims to enhance the body’s immune response to target cancer cells, but not all patients experience a positive reaction to such treatments. Identifying which patients will benefit from immunotherapy... Read more
Microbiology
view channel
Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment
Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes
Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more_1.jpg "Image: Researchers have developed a method to quickly identify the most appropriate treatments for bacterial infections (Photo courtesy of Shutterstock)")
Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment
For patients with bacterial infections, timely treatment with the appropriate antibiotics significantly improves their chances of recovery. Current methods for identifying which antibiotics will be effective... Read more
Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression
Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the... Read morePathology
view channel
Mapping of Atherosclerotic Plaque Cells Predicts Future Risk of Stroke or Heart Attack
Atherosclerosis is the leading cause of cardiovascular diseases like heart attacks and strokes. Over many years, atherosclerotic plaques develop from the accumulation of blood lipids such as cholesterol... Read more
AI Analysis of Immune Cells Predicts Breast Cancer Prognosis
Tumor-infiltrating lymphocytes (TILs) are immune cells crucial in combating cancer. Their presence in a tumor indicates that the immune system is attempting to attack and eliminate cancer cells.... Read more
Technology
view channel
Optical Biosensor Rapidly Detects Monkeypox Virus at Point of Care
A new variant of human mpox has caused a mortality rate of approximately 5% among those infected in the Democratic Republic of the Congo since 2023, with many of the victims being children.... Read more
Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients
Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
New Noninvasive Methods Detect Lead Exposure Faster, Easier and More Accurately at POC
Exposure to lead can negatively affect health in multiple ways, leading to damage in the brain and central nervous system, delays in development and growth, learning and behavioral issues, problems with... Read more
Industry
view channel
Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment
Bio-Techne Corporation (Minneapolis, MN, USA) and ALZpath, Inc. (Carlsbad, CA, USA) have entered into a strategic partnership to accelerate breakthroughs in neurodegenerative disease research and treatment,... Read more
Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID
Microbiologics (St. Cloud, MN, USA), a biotechnology company specializing in infectious disease reference materials and contract research services, has acquired SensID (Rostock, Germany), a manufacturer... Read more
_1.jpg "Image: CACLP 2025 will return on 21-24 March 2025 to attract professionals across the IVD industry (Photo courtesy of CACLP)")